We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$31.8M
Cap. Flow
+$17.7M
Cap. Flow %
7.4%
Top 10 Hldgs %
80.41%
Holding
94
New
15
Increased
22
Reduced
3
Closed
4
Avg Time Held
2 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.06M
2
HHH icon
Howard Hughes
HHH
+$1.86M
3
DAL icon
Delta Air Lines
DAL
+$1.2M
4
DD icon
DuPont de Nemours
DD
+$1.13M
5
AB icon
AllianceBernstein
AB
+$1.08M

Top Sells

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$715K
2
ATCO
Atlas Corp.
ATCO
+$693K
3
HTZ icon
Hertz Global Holdings, Inc.
HTZ
+$495K
4
IIPR icon
Innovative Industrial Properties
IIPR
+$427K
5
MBAI icon
MBody AI Ltd. Ordinary Share
MBAI
+$349K

Sector Composition

Rank Sector Weight
1 Healthcare 73.39%
2 Financials 8.14%
3 Technology 3.76%
4 Real Estate 3.58%
5 Industrials 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.86B
$121M 50.58%
1,599,954
– –
2013 Q2
16 quarters
PFE icon
2
Pfizer
PFE
$169B
$34.8M 14.52%
1,091,603
+65,348
+6% +$2.06M
2013 Q2
16 quarters
CFFN icon
3
Capitol Federal Financial
CFFN
$1.01B
$9.81M 4.09%
690,400
– –
2013 Q2
16 quarters
ABBV icon
4
AbbVie
ABBV
$504B
$5.09M 2.12%
70,200
-3,500
-5% -$235K
2015 Q2
8 quarters
MSFT icon
5
Microsoft
MSFT
$3.93T
$4.74M 1.98%
68,750
– –
2013 Q2
16 quarters
IRDM icon
6
Iridium Communications
IRDM
$4.69B
$3.73M 1.56%
338,000
– –
2014 Q2
12 quarters
APC icon
7
DELISTED
Anadarko Petroleum
APC
$3.66M 1.53%
80,760
– –
2013 Q2
16 quarters
AAPL icon
8
Apple
AAPL
$5.03T
$3.61M 1.51%
100,200
– –
2013 Q2
16 quarters
DAL icon
9
Delta Air Lines
DAL
$50.7B
$3.09M 1.29%
57,500
+24,500
+74% +$1.2M
2015 Q4
6 quarters
OSG icon
10
Octave Specialty Group
OSG
$209M
$2.96M 1.23%
170,426
– –
2013 Q2
16 quarters
AGN
11
DELISTED
Allergan plc
AGN
$2.3M 0.96%
9,446
+200
+2% +$47K
2015 Q4
6 quarters
JPM icon
12
JPMorgan Chase
JPM
$904B
$2.11M 0.88%
23,050
– –
2013 Q2
16 quarters
CXW icon
13
CoreCivic
CXW
$3B
$2.07M 0.86%
75,000
– –
2016 Q4
2 quarters
HHH icon
14
Howard Hughes
HHH
$4.15B
$1.84M 0.77%
+15,735
New +$1.86M
2017 Q2
0 quarters
CHCT icon
15
Community Healthcare Trust
CHCT
$381M
$1.53M 0.64%
60,000
– –
2015 Q2
8 quarters
AVDL
16
DELISTED
Avadel Pharmaceuticals
AVDL
$1.4M 0.58%
126,463
+26,876
+27% +$270K
2015 Q4
6 quarters
AB icon
17
AllianceBernstein
AB
$3.19B
$1.19M 0.5%
50,500
+48,000
+1,920% +$1.08M
2013 Q2
16 quarters
DD icon
18
DuPont de Nemours
DD
$17.8B
$1.19M 0.5%
7,424
+7,108
+2,249% +$1.13M
2015 Q1
9 quarters
DD icon
19
DELISTED
Du Pont De Nemours E I
DD
$1.19M 0.5%
14,700
+8,000
+119% +$639K
2013 Q2
16 quarters
DOC icon
20
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.12M 0.47%
55,800
– –
2013 Q3
15 quarters
KHC icon
21
The Kraft Heinz Company
KHC
$27.8B
$1.02M 0.43%
11,900
– –
2015 Q3
7 quarters
NVLN
22
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.01M 0.42%
109,184
– –
2016 Q4
2 quarters
CPRX icon
23
DELISTED
Catalyst Pharmaceutical
CPRX
$982K 0.41%
355,750
+71,400
+25% +$149K
2017 Q1
1 quarter
GSK icon
24
GSK
GSK
$99.4B
$975K 0.41%
18,080
– –
2014 Q4
10 quarters
MIC icon
25
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$965K 0.4%
12,300
+9,000
+273% +$710K
2014 Q2
12 quarters
1
2 3 4

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2017 Portfolio in Review

As of Q2 2017, David M. Knott held 94 positions worth $240M, up 15% from $208M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

David M. Knott deployed $17.7M of net new capital in Q2 2017, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Howard Hughes: 15,735 shares worth $1.84M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 75% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Acadia Pharmaceuticals, an estimated $715K trimmed.

  • David M. Knott's largest Q2 2017 buy was Howard Hughes: 15,735 shares worth $1.84M.
  • David M. Knott added most to Pfizer in Q2 2017, an estimated $2.06M increase.
  • David M. Knott's biggest Q2 2017 reduction was Acadia Pharmaceuticals, cutting an estimated $715K.
  • David M. Knott fully exited Atlas Corp. in Q2 2017, selling an estimated $693K.
  • David M. Knott's ten largest holdings make up 80% of its $240M portfolio in Q2 2017.
  • David M. Knott opened 15 new positions and closed 4 in Q2 2017.
  • David M. Knott's portfolio value rose 15% quarter-over-quarter to $240M.

Based on David M. Knott's 13F filing for Q2 2017, filed 11 Aug 2017.